68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease

Status Recruiting

Clinical Trial Summary

To evaluate the potential value of 68Ga-FAPI-04 positron emission tomography/ computed tomography (PET/CT) for the diagnosis and prognosis in fibrotic disease

Clinical Trial Description

Subjects with fibrotic disease underwent 68Ga-FAPI-04 PET/CT scanning. Fibrosis lesion uptake was quantified by the maximum standard uptake value (SUVmax). Subjects also received the conventional clinical assessment for liver fibrosis, such as magnetic resonance imaging(MRI) , biopsy and blood biochemical indexes (BBI) testing. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 68Ga-FAPI-04 PET/CT, MRI and BBI were calculated and compared to evaluate the diagnostic efficacy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04831034
Study type	Interventional
Source	First Affiliated Hospital of Fujian Medical University
Contact
Status	Recruiting
Phase	Early Phase 1
Start date	April 1, 2021
Completion date	April 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05570058` - Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis	Phase 2
Completed	`NCT03979417` - Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
Completed	`NCT02408744` - Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease	Phase 1/Phase 2
Active, not recruiting	`NCT00148837` - Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis	Phase 2
Recruiting	`NCT05661123` - Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post Cellulitis	N/A
Recruiting	`NCT04795570` - Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors
Active, not recruiting	`NCT05075785` - Covid-19 Respiratory Sequelae French Cohort
Recruiting	`NCT03308916` - Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers	N/A
Recruiting	`NCT05459259` - Physiotherapy for Arthrofibrosis Following Knee Replacement.
Enrolling by invitation	`NCT01483248` - Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis	Phase 1/Phase 2
Completed	`NCT00001729` - Combination Drug Therapy for Patients With Hepatitis C	Phase 3
Completed	`NCT02049307` - Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial	Phase 2
Active, not recruiting	`NCT05685823` - The Impact of Conventional Hemodialysis and Renal Transplantation on the Global Longitudinal Strain of the Left Ventricle
Completed	`NCT00744939` - Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist	Phase 4
Completed	`NCT00252642` - Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C	N/A
Recruiting	`NCT04934202` - Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France
Completed	`NCT02604862` - Imaging FIB ONE in the Human Lung Using Endomicroscopy	Early Phase 1
Completed	`NCT02774161` - B-mode Ultrasound Imaging in Detecting Early Liver Cancer	N/A
Active, not recruiting	`NCT01246388` - Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy	N/A
Completed	`NCT02161952` - Pirfenidone, an Antifibrotic and Antiinflammatory Drug	Phase 2